Doxy 100(tm) Doxycycline Injection, Powder, Lyophilized, For Solution
NDC Package 51662-1402-3
Package Information
Doxy 100(tm) Doxycycline injection is a medication used to treat a wide variety of bacterial infections, including those that cause acne. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Hf Acquisition Co Llc, Dba Healthfirst, this product is identified by NDC 51662-1402 and is authorized under FDA application ANDA062475.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51662 - Hf Acquisition Co Llc, Dba Healthfirst
- 51662-1402 - Doxy 100(tm) Doxycycline
- 51662-1402-3 - 10 POUCH in 1 BOX / 1 VIAL in 1 POUCH (51662-1402-2) / 10 mL in 1 VIAL
- 51662-1402 - Doxy 100(tm) Doxycycline
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51662-1402). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51662-1402-3 identifies a specific commercial package of 10 pouch in 1 box / 1 vial in 1 pouch (51662-1402-2) / 10 ml in 1 vial of Doxy 100(tm) Doxycycline, a human prescription drug labeled by Hf Acquisition Co Llc, Dba Healthfirst. This injection, powder, lyophilized, for solution is formulated for intravenous use and contains doxycycline hyclate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hf Acquisition Co Llc, Dba Healthfirst on October 07, 2019. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Hf Acquisition Co Llc, Dba Healthfirst product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51662140203. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.